Top Markets
Coin of the day
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Rang în acțiuni #40889
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Preț acțiune
$0.0127
Ultima sincronizare: 2026-08-12
Capitalizare de piață
$66.48K
Schimbare (1 zi)
-2.31%
Schimbare (1 an)
-67.44%
Țară
US
Tranzacționează Vincerx Pharma, Inc. (VINC)

Categorie

Istoric al prețului acțiunii pentru Vincerx Pharma, Inc. (VINC)
Cel mai mare preț de închidere: $0.01 pe 2026-08-01

Cel mai mic preț de închidere: $195.93 pe 2020-05-01
Istoric al prețului acțiunii pentru Vincerx Pharma, Inc. din 2020 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 86.64%
2025 -99.71%
2024 -70.59%
2023 -10.91%
2022 -91.75%
2021 -41.58%
2020 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$522.59 31.99%
US
$863.65 33.57%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE